Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dale T Umetsu

Showing results (121-130 of 126) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 126 results.
The Journal of Allergy and Clinical Immunology|May 31, 2019
Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohortJennifer A Namazy, Lucie Blais, Elizabeth B Andrews, et al.
Immunity|December 18, 2007
TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cellsNorimoto Kobayashi, Piia Karisola, Victor Peña-Cruz, et al.
The Journal of Experimental Medicine|July 4, 2007
Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector functionSheng Xiao, Nader Najafian, Jay Reddy, et al.
The Journal of Clinical Investigation|December 16, 2010
Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivityYa-Jen Chang, Hye Young Kim, Lee A Albacker, et al.
The Journal of Allergy and Clinical Immunology|September 10, 2016
Omalizumab facilitates rapid oral desensitization for peanut allergyAndrew J MacGinnitie, Rima Rachid, Hana Gragg, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Protocol design and synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multiallergen OIT in Children and Adults with Food Allergy (OUtMATCH)Robert A Wood, R Sharon Chinthrajah, Amanda K Rudman Spergel, et al.
Pageof 13

Showing results (121-130 of 126) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 126 results.
The Journal of Allergy and Clinical Immunology|May 31, 2019
Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohortJennifer A Namazy, Lucie Blais, Elizabeth B Andrews, et al.
Immunity|December 18, 2007
TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cellsNorimoto Kobayashi, Piia Karisola, Victor Peña-Cruz, et al.
The Journal of Experimental Medicine|July 4, 2007
Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector functionSheng Xiao, Nader Najafian, Jay Reddy, et al.
The Journal of Clinical Investigation|December 16, 2010
Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivityYa-Jen Chang, Hye Young Kim, Lee A Albacker, et al.
The Journal of Allergy and Clinical Immunology|September 10, 2016
Omalizumab facilitates rapid oral desensitization for peanut allergyAndrew J MacGinnitie, Rima Rachid, Hana Gragg, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Protocol design and synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multiallergen OIT in Children and Adults with Food Allergy (OUtMATCH)Robert A Wood, R Sharon Chinthrajah, Amanda K Rudman Spergel, et al.
Pageof 13